NKTR $73.02 -3.82%

NKTR · Nektar Therapeutics

$73.02 -2.90 (-3.82%) At close · Aug 14

Market Cap

$2.49B

34.14M

Earnings call · FY2024 Q2

Nektar Therapeutics Q2 FY2024 Earnings Call

Concluded Aug 8, 2024

Aug 8, 2024 0 turns

Executive readout · one minute

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $23.49M +14.6% YoY

Diluted EPS -$3.76

Net income -$52.36M

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 8, 2024 10-Q report Filed Aug 9, 2024

How the reported period landed and where the business moved.

Non Cash Royalty Revenue Related to Sale of Future Royalties$16.79M +6.1% YoY

Product$6.64M +42.6% YoY

License Collaboration and Other Revenue$59,000 +555.6% YoY